Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Genetic Technologies Ltd (NASDAQ:GENE)

1.17
Delayed Data
As of Mar 24
 +0.03 / +2.63%
Today’s Change
1.04
Today|||52-Week Range
2.89
+8.33%
Year-to-Date
No recent news for Genetic Technologies Ltd.

Today’s Trading

Previous close1.14
Today’s open1.15
Day’s range1.15 - 1.30
Volume1,143,157
Average volume (3 months)615,480
Market cap$19.0M
Dividend yield--
Data as of 3:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)+47.79%
Earnings growth (this year)+838.23%
Earnings growth (next 5 years)--
Revenue growth (last year)-64.19%
P/E ratioNM
Price/Sales39.83
Price/Book1.51

Competitors

 Today’s
change
Today’s
% change
APTOAptose Biosciences I...+0.01+0.88%
PZRXPhaseRx Inc+0.01+0.67%
VTGNVistaGen Therapeutic...-0.13-6.40%
ORPNBioblast Pharma Ltd-0.02-2.20%
Data as of 3:59pm ET, 03/24/2017

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$600.0K
Annual profit (last year)-$6.2M
Net profit margin-1,025.84%

Profile

Sector
Health Technology
Industry
Biotechnology
CEO, Chief Operating Officer &
Executive Director
Eutillio Buccilli
Chief Financial Officer &
Secretary
Kevin Fischer
Corporate headquarters
Fitzroy, Victoria (vic)

Forecasts


Search for Jobs